About Hospital Abente y Lago
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Ionis Pharmaceuticals, Inc.
2
Amryt Pharma
1
Novartis Pharmaceuticals
1
Pfizer
1
Clinical Trials at Hospital Abente y Lago
During the past decade, Hospital Abente y Lago conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) Administered to Patients With Familial Chylomicronemia Syndrome (FCS)
2020-11-16
2023-10-01
Active, not recruiting
66
Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Heterozygous Familial Hypercholesterolemia
2021-01-27
2024-12-03
Active, not recruiting
141
Efficacy and Safety of Lomitapide in Paediatric Patients With Homozygous Familial Hypercholesterolaemia (HoFH)
2020-12-14
2024-04-30
Active, not recruiting
46
A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia
2021-10-25
2025-02-01
Recruiting
540
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Abente y Lago"
#1 collaborator was "Akcea Therapeutics" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Hospital Abente y Lago
According to Clinical.Site data, the most researched conditions in "Hospital Abente y Lago" are
"Cardiovascular Disease" (1 trials), "Familial Chylomicronemia Syndrome" (1 trials), "Familial Hypercholesterolemia - Heterozygous" (1 trials), "Homozygous Familial Hypercholesterolaemia (HoFH)" (1 trials) and "Severe Hypertriglyceridemia" (1 trials). Many other conditions were trialed in "Hospital Abente y Lago" in a lesser frequency.
Clinical Trials Intervention Types at Hospital Abente y Lago
Most popular intervention types in "Hospital Abente y Lago" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Olezarsen" (2 trials), "Inclisiran" (1 trials), "Lomitapide" (1 trials) and "bococizumab (PF-04950615)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital Abente y Lago
The vast majority of trials in "Hospital Abente y Lago" are
5 trials for "All" genders.
Clinical Trials Status at Hospital Abente y Lago
Currently, there are NaN active trials in "Hospital Abente y Lago".
undefined are not yet recruiting,
1 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Hospital Abente y Lago,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Abente y Lago, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".